Abstract
A series of analogues of the pyrazole lead 1 were synthesized in which the heterocyclic core was replaced with an imidazole. A number of potent antagonists were identified and structure-activity relationships (SAR) were investigated both with respect to activity at the P2X(7) receptor and in vitro metabolic stability. Compound 10 was identified as a potent P2X(7) antagonist with reduced in vitro metabolism and high solubility.
2010 Elsevier Ltd. All rights reserved.
MeSH terms
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / chemical synthesis*
-
Anti-Inflammatory Agents, Non-Steroidal / chemistry
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacology
-
Humans
-
Imidazoles / chemical synthesis
-
Imidazoles / chemistry*
-
Imidazoles / pharmacology
-
Purinergic P2 Receptor Antagonists*
-
Pyrazoles / chemistry
-
Rats
-
Receptors, Purinergic P2 / metabolism
-
Receptors, Purinergic P2X7
-
Structure-Activity Relationship
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Imidazoles
-
P2RX7 protein, human
-
Purinergic P2 Receptor Antagonists
-
Pyrazoles
-
Receptors, Purinergic P2
-
Receptors, Purinergic P2X7
-
pyrazole